Phase 1 trial shows NGM621 for GA is well tolerated by study participants
Investigation evaluates safety of single and multiple intravitreal injections.
Related Articles
Pantheon Vision holds two pre-submission meetings with FDA
According to the company, the feedback from the interactive meetings will provide guidance for the path to a PMA submission.
The role of multimodal imaging in ocular trauma
Closed globe ocular injury often leads to macular pathology
ASCRS 2024: Ultra-low cylinder powered toric versus non-toric lenses in cataract surgery
Adam Muzychuk, MD, BSc, FRCSC discusses his presentation, “Outcomes of an ultra-low cylinder powered (0.90) toric versus non-toric in low astigmatic patients undergoing cataract surgery.”
Ophthalmologists embrace potential of clinically tested nutraceuticals for dry eye disease
Look beyond isolated treatment of the eye to address systemic factors.
Comparing ChatGPT 3.5, Microsoft Bing, and Google Gemini in diagnosing cases of neuro-ophthalmology
A brief analysis showed that ChatGPT 3.5 performed better.
Using extracellular vesicles in the treatment of ocular diseases
Shift could lead to changes in the current management of retinal diseases
The evolving role of vitreosurgical simulators in surgical training
Need to eliminate errors results in optimization of training of novice surgeons.
Study evaluates the potential correlation of ultra-processed food consumption and increased glaucoma incidence
UPFs include fast food, energy drinks and soda, sweets such as chocolates and candies and much more.
The role of multimodal imaging in ocular trauma
Closed globe ocular injury often leads to macular pathology
What’s Your WhEYE? A conversation with Paul Badawi, CEO of Sight Sciences
Paul Badawi, co-founder and CEO of Sight Sciences, sits down with host Neda Shamie, MD, to discuss his journey into the field of eye care,…